The restoration of these endogenous deficiencies (i.e., boosting local steroidogenesis and the effects of POMC/glucocorticoids) is seen as a “realistic target” for treating psoriasis and other inflammatory skin disorders. This evidence concerns the gene POMC and psoriasis.